PRA Health Sciences to Report Third Quarter 2016 Earnings

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PRA Health Sciences to Report Third Quarter 2016 Earnings

RALEIGH, N.C., Oct. 10, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) will release its third quarter 2016 results after the market closes on Wednesday, November 2. The Company will also host a conference call on Thursday, November 3 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

To participate via telephone, investors and analysts should dial (877) 930-8062 within the United States or (253) 336-7647 outside the United States approximately 10 minutes prior to the call start time. The conference ID for the call is 97800997. An audio replay of the call will be available for one week following the call and can be accessed by dialing (855) 859-2056 within the United States or (404) 537-3406 outside the United States. The replay ID is 97800997.

A live audio broadcast will be available on the investor relations section of the PRA Health Sciences website. Following the teleconference, the presentation and an audio playback of the call will be available at the same website.

ABOUT PRA HEALTH SCIENCES

PRA is one of the world's leading global contract research organizations, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East, and approximately 12,000 employees worldwide. Since 2000, PRA has performed approximately 3,300 clinical trials worldwide and has worked on more than 100 marketed drugs across several therapeutic areas. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 60 drugs. To learn more about PRA, please visit www.prahs.com .

CONTACTS: Luke Heagle Pure Communications, Inc. Director, Investor Relations 910.726.1372 InvestorRelations@PRAHS.com or luke@purecommunicationsinc.com Christine Rogers PRA Health Sciences, Inc. Director, Public Relations 919.786.8463 rogerschristine@prahs.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revolutionizing Employee Benefits with Universal Care Groups

Updated Category News Views 247

Universal Care Groups LLC Introduces Innovative Healthcare Solutions Universal Care Groups LLC (“UCG”) is making significant strides in the healthcare sector with its introduction of a cutting-edge platinum Section 125 Cafeteria plan and Minimum Essential Coverage (MEC) options designed specifically for employers and employees. This innovative approach is set to...

Continue Reading
Rezolute Inc. Reveals Financial Outcomes and Business Insights

Updated Category News Views 115

Rezolute Inc. Financial Results Overview Rezolute, Inc. (NASDAQ: RZLT) is making significant strides in the biopharmaceutical industry, particularly focusing on treating hypoglycemia resulting from hyperinsulinism. In a recent financial report, Rezolute presented its outcomes for the fourth quarter and the full fiscal year trailing off June 30, 2025. Key Business...

Continue Reading
Elite Longevity Program Offers Immortality Insights for $1 Million

Updated Category News Views 223

Exploring the Latest in Longevity Science Renowned tech entrepreneur Bryan Johnson is capturing attention with his ambitious approach to anti-aging. His latest endeavor, a premium health program, aims to provide unparalleled longevity insights to just three individuals willing to invest $1 million per year. It’s a groundbreaking facility engineered from years of...

Continue Reading
Star Refrigeration: Key Insights at Cold Chain Live 2025

Updated Category News Views 185

Star Refrigeration Takes the Stage at Cold Chain Live 2025 Star Refrigeration is poised to make a significant impact at Cold Chain Live 2025 as a Platinum Sponsor. This prestigious event gathers industry leaders, operators, and innovators working within the temperature-controlled logistics sector, taking place at the Telford International Centre. Insightful Presentations...

Continue Reading
Max Stock Limited Reveals New Employment for Eliad Max

Updated Category News Views 192

Max Stock Limited Discloses Eliad Max's Employment Max Stock Limited (TASE: MAXO) has made an important announcement regarding the employment of Mr. Eliad Max, son of company's CEO, Mr. Ori Max. This decision was disclosed following approvals from the remuneration committee and the board of directors. Details of the Employment Agreement On two separate occasions, the...

Continue Reading